| ID | Title | Body | Facebook Description | Facebook image | Facebook Title | Facebook Video | Twitter Description | Twitter Image | Twitter Title | Meta tags |
|---|---|---|---|---|---|---|---|---|---|---|
| 8259 | Pfizer's Centers for Therapeutic Innovation (CTI) for NIH Researchers | NCATS leads an innovative collaboration for the NIH with Pfizer's Centers for Therapeutic Innovation (CTI) that is designed to help bridge the gap between early scientific discovery and its translation into new medicines through public-private resource-sharing. Learn more about the CTI. | Pfizer's Centers for Therapeutic Innovation for NIH researchers aims to bridge the gap between early scientific discovery and its translation into new medicines through public-private collaborations. | Pfizer's Centers for Therapeutic Innovation (CTI) | Pfizer's Centers for Therapeutic Innovation for NIH researchers aims to bridge the gap between early scientific discovery and its translation into new medicines through public-private collaborations. | Pfizer's Centers for Therapeutic Innovation (CTI) | ||||
| 8258 | Multimedia | Review NCATS' collection of resources for the media, including photos, audio segments and videos. | Explore NCATS’ collection of multimedia resources, including videos, photos and infographics | Multimedia | Explore NCATS’ collection of multimedia resources, including videos, photos and infographics | Multimedia | ||||
| 8227 | Discovering New Therapeutic Uses for Existing Molecules | Through its Discovering New Therapeutic Uses for Existing Molecules (New Therapeutic Uses) program, NCATS aims to improve the process of developing new treatments and cures for disease by finding new uses for existing therapies that already have cleared several key steps along the development path. Learn more about New Therapeutic Uses. | /sites/default/files/ntu-awards_900x400.jpg | Discovering New Therapeutic Uses for Existing Molecules | /sites/default/files/ntu-awards_900x400.jpg | Discovering New Therapeutic Uses for Existing Molecules | ||||
| 8226 | Early Translation Branch (ETB) | ETB scientists bring unique expertise and diverse interests to research projects and collaborations to help kick-start the early discovery pathway. The team creates tools and technologies that enable the de-risking of potential targets and modalities for treating diseases. Learn more about ETB. | ETB researchers advance small molecule therapeutic development through assay (test) design, high-throughput screening and medicinal chemistry. | /sites/default/files/ampk-900px.jpg | Early Translation Branch (ETB) | ETB researchers advance small molecule therapeutic development through assay (test) design, high-throughput screening and medicinal chemistry. | /sites/default/files/ampk-900px.jpg | Early Translation Branch (ETB) | ||
| 8225 | Functional Genomics Lab | Developing and improving functional genomics (RNAi and CRISPR/Cas9) screening approaches to better understand gene function and identify biologically-relevant targets. NCATS' state-of-the-art RNAi screening facility accepts proposals from any NIH researcher. NCATS staff assist investigators with all stages of project planning and execution, from assay development through genome-wide small-interfering RNA (siRNA) screens, informatics and pathway analysis, and rigorous follow-up. Learn more about the Functional Genomics Lab at NCATS. | ||||||||
| 8224 | News & Events (old D7) | Find out about the latest news and events from NCATS and from its partners.!function(c,h,i,m,p){m=c.createElement(h),p=c.getElementsByTagName(h)[0],m.async=1,m.src=i,p.parentNode.insertBefore(m,p)}(document,"script","https://chimpstatic.com/mcjs-connected/js/users/e06bd55ccbb41f1a362306dff/9c199175ea7b167e2bdb5384e.js"); | Find out about the latest news and events from NCATS and from its partners. | News & Events | Find out about the latest news and events from NCATS and from its partners. | News & Events | ||||
| 8223 | Small Business Opportunities | NCATS' Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs help small businesses develop and commercialize new translational technologies. Learn More. | NCATS' Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs help small businesses develop and commercialize new translational technologies. | Small Business Opportunities | NCATS' Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs help small businesses develop and commercialize new translational technologies. | Small Business Opportunities | ||||
| 8222 | Patient/Community Engagement & Health Information | To ensure patient involvement and community engagement throughout the research process, institutions must collaborate with community organizations and patient groups to identify and understand public health needs. | /sites/default/files/rare_diseases_resources_banner_900x600_2.png | /sites/default/files/rare_diseases_resources_banner_900x600_3.png | ||||||
| 8221 | Expertise & Resources | #featured-stories > #secondary-image > .img-responsive { min-height: 312px; } NCATS staff are experts in many different fields relevant to translational research and science policy, from small molecules to human subjects protections. NCATS also offers a variety of tools and other resources for preclinical and clinical investigators. | NCATS staff are experts in many different fields relevant to translational research and science policy, from small molecules to human subjects protections | /sites/default/files/expertise-resources.jpg | Expertise & Resources | NCATS staff are experts in many different fields relevant to translational research and science policy, from small molecules to human subjects protections | /sites/default/files/expertise-resources.jpg | Expertise & Resources | ||
| 8220 | Advisory Groups | Find more details about the two federal advisory groups that provide input and guidance to NCATS leadership. |
Last updated on